Search research articles
Contact Us
Filters
Showing results (81-90 of 223) with videos related to
Page
of 23
Sort By:
Urology
|
July 23, 2011
Impact of cytoreductive nephrectomy on eligibility for systemic treatment and effects on survival: are surgical complications or disease related factors responsible?
Rebecca L O'Malley, Katherine A Brewer, Matthew H Hayn, et al.
Cancers
|
June 21, 2020
The Combination of Low Skeletal Muscle Mass and High Tumor Interleukin-6 Associates with Decreased Survival in Clear Cell Renal Cell Carcinoma
Joshua K Kays, Leonidas G Koniaris, Caleb A Cooper, et al.
Plos One
|
February 4, 2012
Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models
Li Shen, Michael Ciesielski, Swathi Ramakrishnan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2005
Marimastat in the treatment of patients with biochemically relapsed prostate cancer: a prospective randomized, double-blind, phase I/II trial
Eli Rosenbaum, Marianna Zahurak, Victoria Sinibaldi, et al.
BMC Cancer
|
February 4, 2010
Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model
Jacob E Koskimaki, Emmanouil D Karagiannis, Benjamin C Tang, et al.
Investigational New Drugs
|
December 22, 2010
A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate
Justine Yang Bruce, Jens Eickhoff, Roberto Pili, et al.
Cancer Research
|
May 1, 2002
Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer
Silvia M Sirchia, Mingqiang Ren, Roberto Pili, et al.
ACS Sensors
|
August 26, 2017
Real-Time Multiplex Kinase Phosphorylation Sensors in Living Cells
Nur P Damayanti, Kevin Buno, Yi Cui, et al.
Cancer Research
|
September 5, 2006
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha
David Z Qian, Sushant K Kachhap, Spencer J Collis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 24, 2011
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examination
Daniel Keizman, Peng Huang, Mario A Eisenberger, et al.
Page
of 23
Search research articles
Search
Showing results (81-90 of 223) with videos related to
Sort By:
Page
of 23
Urology
|
July 23, 2011
Impact of cytoreductive nephrectomy on eligibility for systemic treatment and effects on survival: are surgical complications or disease related factors responsible?
Rebecca L O'Malley, Katherine A Brewer, Matthew H Hayn, et al.
Cancers
|
June 21, 2020
The Combination of Low Skeletal Muscle Mass and High Tumor Interleukin-6 Associates with Decreased Survival in Clear Cell Renal Cell Carcinoma
Joshua K Kays, Leonidas G Koniaris, Caleb A Cooper, et al.
Plos One
|
February 4, 2012
Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models
Li Shen, Michael Ciesielski, Swathi Ramakrishnan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2005
Marimastat in the treatment of patients with biochemically relapsed prostate cancer: a prospective randomized, double-blind, phase I/II trial
Eli Rosenbaum, Marianna Zahurak, Victoria Sinibaldi, et al.
BMC Cancer
|
February 4, 2010
Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model
Jacob E Koskimaki, Emmanouil D Karagiannis, Benjamin C Tang, et al.
Investigational New Drugs
|
December 22, 2010
A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate
Justine Yang Bruce, Jens Eickhoff, Roberto Pili, et al.
Cancer Research
|
May 1, 2002
Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer
Silvia M Sirchia, Mingqiang Ren, Roberto Pili, et al.
ACS Sensors
|
August 26, 2017
Real-Time Multiplex Kinase Phosphorylation Sensors in Living Cells
Nur P Damayanti, Kevin Buno, Yi Cui, et al.
Cancer Research
|
September 5, 2006
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha
David Z Qian, Sushant K Kachhap, Spencer J Collis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 24, 2011
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examination
Daniel Keizman, Peng Huang, Mario A Eisenberger, et al.
Page
of 23